𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modelling the costs and effects of leflunomide in rheumatoid arthritis

✍ Scribed by G. Kobelt; P. Lindgren; A. Young


Book ID
106294738
Publisher
Springer
Year
2002
Tongue
French
Weight
400 KB
Volume
3
Category
Article
ISSN
1618-7598

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Leflunomide use and the risk of intersti
✍ Samy Suissa; Marie Hudson; Pierre Ernst πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 66 KB πŸ‘ 2 views

## Abstract ## Objective Spontaneous reports of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) treated with leflunomide, a disease‐modifying antirheumatic drug (DMARD), have been appearing recently. To assess this risk, we conducted a population‐based epidemiologic stud

The safety and efficacy of leflunomide i
✍ Hansen, K. E. ;Cush, J. ;Singhal, A. ;A. Cooley, D. ;Cohen, S. ;Patel, S. R. ;Ge πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 2 views

## Objective: To report the safety and efficacy of leflunomide (lef) in combination with infliximab (inf) for the treatment of rheumatoid arthritis. ## Methods: In an open, multicenter, retrospective study, data were collected on the safety and efficacy of lef and inf. ## Results: Eighty-eight